Company intelligence / Profile preview

Diazyme Laboratories

Poway, California, United Statesdiazyme.com ↗

Ownership: Private
Employees: ~87
Development stage: Commercial

Overview

Diazyme Laboratories develops and manufactures innovative clinical diagnostic reagents using proprietary enzyme and immunoassay technologies. Their products address unmet needs in diagnostics for cardiovascular disease, cancer, liver/kidney disorders, diabetes and more. They have a global presence with commercialized products compatible with most automated chemistry analyzers.

Therapeutic areas: OncologyEndocrinologyImmunologyHematologyGastroenterologyCardiovascularNephrologyInfectious Diseases
Modalities: Enzymatic assay (Enzyme)Immunoassay (Antibody)Small molecule sandwich assay (Small molecule)Chemiluminescent immunoassay (CLIA)Recombinant protein
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Diazyme Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diazyme Laboratories.

Explore the full profile